Publications

19

Apr, 2000

Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.

 

Authors: Bernardi S, Thorne C, Newell ML, Giaquinto C,Tovo PA, Rossi P.

Published in: European Journal of Pediatrics 2000; 159(3):170-5

Read

18

Apr, 2000

Reconstitution of the T-cell Pool in Treated, HIV-infected Children.

 

Authors: King D, Gibb DM, Gotch F, Larsson-Sciard E.

Published in: 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, January 30- February 2, 2000. Abstract 322.

18

Apr, 2000

Immune repopulation after HAART in previously untreated HIV-1 infected children.

 

Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Wörner I, Babiker A

Published in: The Lancet 2000; 355: 1331-2.

Read

18

Apr, 2000

A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial.

 

Authors: Gibb. D. M. for the PENTA 5 Executive and the PENTA Steering Committee.

Published in: Oral presentation at 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000 also published in AIDS 2000, Vol 14, supp4 p.58 (abstractPL6.8)

18

Apr, 2000

Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)

 

Authors: Kaye S. on behalf of the PENTA Virology Committee.

Published in: 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000. Poster 308.

1

Oct, 1999

Parents’ attitudes to their HIV-infected children being enrolled into a placebo-controlled trial: the PENTA 1 trial. Paediatric European Network for Treatment of AIDS.

 

The study aimed to explore the experience of parents/care-givers to their child’s participation in a European randomized trial of immediate (zidovudine) with deferred (placebo) antiretroviral treatment in asymptomatic children with vertically acquired HIV infection (PENTA 1 trial).

Published in: HIV Med. 1999;1(1):25-31.

 

Read

18

Apr, 1998

Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial).

 

Authors:  Kaye S, Loveday C, Gibb DM., Newberry A.

Published in: IVth International Congress Glasgow, 8-12 November 1998. Abstract P305

12

Apr, 1998

A randomised double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial

 

Author: Aboulker JP, Babiker A, Carrière I, Darbyshire JH Debré M, Giaquinto C, Gibb DM, Harper L, Newberry A, Saidi Y, Tudor-Williams G.

Published in: AIDS 1998; 12 F151-F160.

Read

5

Mar, 1998

HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).

 

Published in: Aids. 1998;12(4):F1-8.

Read

18

Oct, 1997

The Safety and Tolerability of Zidovudine (ZDV) and Zalcitabine (ddC) in Children with Symptomatic HIV Infection – PENTA 3 (Abstract)

 

Authors:  Gibb DM, Carrière I, Giaquinto C, Martinez M for PENTA.

Published in: VIth European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany 1-15 October, 1997.